Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors
Virtual Event
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA)